RecruitingISRCTN23496771
Metformin versus placebo to limit weight gain with antipsychotic treatment in severe mental health conditions
About this title
Metformin for Antipsychotic-Induced Weight Gain in People with Severe Mental Illness
Read the official source — ISRCTN23496771Research studyAges 18–100Pakistan
Understand this study
Who could participate?
Listed age limits: 18 years to 100 years.
- Listed locations
- Pakistan
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University of York
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Pakistan
- Age range
- From 18 Years to 100 Years
- Official registry ID
- ISRCTN23496771
- Official title
Show the full official title
The effectiveness of Metformin for reducing weight gain experienced by people with severe mental health problems in South Asia
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Pakistan
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of York, a university.
Who can participate?
Listed age limits: 18 years to 100 years.
Is this study still recruiting?
The registry lists this study as recruiting.
